Latest Commercialization News

The Lottery Corporation has locked in a 40-year extension of its Victorian Public Lottery Licence to 2068, paying a $1.145 billion upfront premium funded by debt and revising its dividend policy to distribute 80-100% of NPATA from FY27.

Nine Entertainment’s acquisition of QMS Media and sale of Nine Radio mark a strategic pivot, with strong Q3 digital and subscription revenue growth cushioning a cautious Q4 advertising environment.

Adisyn has appointed Tamir Zimber, a former Israeli Air Defence Colonel and current senior IAI executive, to its new Advisory Board, aiming to accelerate commercialisation of its graphene-based radar absorption technology.

Holista Colltech has partnered with Swang Chai Chuan to develop a nano-collagen production facility in Western Australia, marking a major step in commercialising its collagen technology with a $1.6 million initial investment.

Dreadnought Resources has reported some of the highest-grade gold intercepts yet at Metzke’s Find, extending mineralisation beyond its 2023 resource and setting the stage for a resource upgrade in July 2026.

Pure Resources has demonstrated that its Carbon Nanotube Fibre (CNTF) achieves thermal conductivity up to 600 W/m·K, outperforming copper by 1.5 times and aluminium by up to 3 times, positioning it as a breakthrough for AI, defence, and high-power electronics cooling.

Westpac Banking Corporation posted a statutory net profit of AUD 3.414 billion for the half year ended March 2026, marking a 3% increase on the prior corresponding period despite a 5% decline from the previous half. The bank maintained a strong capital position and declared a fully franked interim dividend of 77 cents per share.

Connected Minerals (ASX:CML) is set to acquire Frontier Group CRM, gaining control of an 80% interest in the Bailundo carbonatite project in Angola, boasting near-surface high-grade niobium and rare earth mineralisation. Backed by a $4.5 million capital raise, the company aims to fast-track exploration in this emerging critical minerals jurisdiction.

Murray Cod Australia (ASX:MCA) is raising $18.6 million through a fully underwritten entitlement offer at a steep 43% discount to last price, aiming to convert its record 3,700-tonne biomass into sales and expand processing capacity.

Delorean Corporation has launched a $2.2 million Share Purchase Plan at $0.09 per share, matching a recent strategic placement to LMS Energy. The capital raise supports construction of key bioenergy projects in South Australia and New South Wales.

ImpediMed has secured A$15.2 million through a two-tranche placement and share purchase plan, alongside A$5 million in cost reductions, aiming for operating cashflow breakeven by H2 FY28.

AdAlta has secured A$2.5 million in a strategic placement to push its lead CAR-T therapy BZDS1901 through critical US FDA regulatory steps and establish Australian manufacturing, building on promising clinical responses in advanced mesothelioma.